-
EP1927351
European procedure
Extract from the Register of European Patents
EP About this file: EP1927351
| EP1927351 - Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.08.2011 Database last updated on 02.09.2024 | Most recent event Tooltip | 01.03.2013 | Change - lapse in a contracting state State(s) deleted from list of lapses: IT | published on 03.04.2013 [2013/14] | Applicant(s) | For all designated states Les Laboratoires Servier 12, Place de La Défense 92415 Courbevoie Cedex / FR | [2008/23] | Inventor(s) | 01 /
Spedding, Michael 6, rue Ampère 78110 Vesinet / FR | 02 /
Mocaer, Elisabeth 32, rue Chauveau 92200 Neuilly sur Seine / FR | [2008/23] | Application number, filing date | 07291392.4 | 23.11.2007 | [2008/23] | Priority number, date | FR20060010294 | 24.11.2006 Original published format: FR 0610294 | [2008/23] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | EP1927351 | Date: | 04.06.2008 | Language: | FR | [2008/23] | Type: | B1 Patent specification | No.: | EP1927351 | Date: | 06.10.2010 | Language: | FR | [2010/40] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.03.2008 | Classification | IPC: | A61K31/165, A61P25/00 | [2008/23] | CPC: |
A61K31/165 (EP,KR,NO,US);
A61P25/00 (EP);
A61P25/22 (EP);
A61P25/28 (EP);
A61P43/00 (EP);
A61P9/10 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/23] | Extension states | AL | 30.11.2007 | BA | 30.11.2007 | HR | 30.11.2007 | MK | 30.11.2007 | RS | 30.11.2007 | Title | German: | Einsatz von Agomelatin zur Herstellung von Medikamenten zur Behandlung von periventrikulärer Leukomalazie | [2008/23] | English: | Use of agomelatine to obtain medication aimed at treating periventricular leukomalacia | [2008/23] | French: | Utilisation de l'agomélatine pour l'obtention de médicaments destinés au traitement de la leucomalacie périventriculaire | [2008/23] | Examination procedure | 30.11.2007 | Examination requested [2008/23] | 18.11.2008 | Despatch of a communication from the examining division (Time limit: M06) | 19.05.2009 | Reply to a communication from the examining division | 22.07.2009 | Despatch of a communication from the examining division (Time limit: M02) | 21.09.2009 | Reply to a communication from the examining division | 05.05.2010 | Communication of intention to grant the patent | 17.08.2010 | Fee for grant paid | 17.08.2010 | Fee for publishing/printing paid | Opposition(s) | 07.07.2011 | No opposition filed within time limit [2011/37] | Fees paid | Renewal fee | 31.10.2009 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2013/14] |
| Former [2012/03] | IT | 23.11.2010 | Documents cited: | Search | [DXY]EP1564202 (SERVIER LAB [FR]) [DX] 3-6 * paragraph [0004] * * claims 18-20 * [Y] 1,2; | [Y] - HUSSON ISABELLE ET AL, "Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge", ANNALS OF NEUROLOGY, (200201), vol. 51, no. 1, ISSN 0364-5134, pages 82 - 92, XP002442543 [Y] 1,2 * the whole document * DOI: http://dx.doi.org/10.1002/ana.10072 | by applicant | EP0447285 | EP1564202 |